Skip to main content

Advertisement

Log in

Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The present study was designed to research on RNA interference hepatitis B virus x gene approach to hepatocellular carcinoma (HCC) therapy. Previously, we constructed and identified shRNA eukaryotic expression vectors (pshRNA-X220) specific to HBx gene, pshRNA-MOCK (control); and established HCC cell lines with stable expression shRNA eukaryotic vector targeting HBx gene—21543 cell lines (MHCC97-H of expressing shRNA against HBx), HK3 cell lines (MHCC97-H by transfected with pshRNA-MOCK). We examined the expression of HBx gene after RNA interference by semi-quantitative RT-PCR and assessed the effect of HBx knocked down on cell growth by proliferation assay using kit-8 (CCK8). As well as, we analyzed cell cycle distribution by flowcytometry and examined cell apoptosis using TUNEL assay. The HBx mRNA expression level is reduced, and cells growth was significantly stopped in 21543 cell lines. Cells with HBx knockdown were more sensitive to 5-fluorouracil/cisplatin. RNA interfering HBx induced an obvious time and dose-dependent inhibitory in comparison with the control cells. Meanwhile, RNA interferenced targeting HBx, in combination with chemotherapy can effectively induce apoptosis in hepatocellular carcinoma cells and restricts cell proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wang WL, London WT, Feitelson MA. Hepatitis B × antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 1991;51(18):4971–7.

    CAS  PubMed  Google Scholar 

  2. Feitelson MA, Duan LX. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol. 1997;150(4):1141–57.

    CAS  PubMed  Google Scholar 

  3. Nowak AK, Chow PK, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur J Cancer. 2004;40(10):1474–84.

    Article  CAS  PubMed  Google Scholar 

  4. Wang WL, et al. Identification and construction of shRNA for targeted HBx gene integrated to MHCC-97H cell line. J China medical univ. 2008;37(4):445–7.

    Google Scholar 

  5. Xing-e HE, et al. Establishment of human hepatocellular carcinoma cell line expressing HBx shRNA. Zhonghua Gan Zang Bing Za Zhi. 2009;17(4):310–2.

    Google Scholar 

  6. Michielsen PP, Francque SM, van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol. 2005;3:27–32.

    Article  PubMed  Google Scholar 

  7. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–87.

    Article  CAS  PubMed  Google Scholar 

  8. Haviv I, Shamay M, Doitsh G, Shaul Y. Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol. 1998;18(3):1562–9.

    CAS  PubMed  Google Scholar 

  9. Milich DR, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero ? Proc Natl Acad Sci U S A. 1990;87(17):6599–603.

    Article  CAS  PubMed  Google Scholar 

  10. Wei Y, et al. Identification of beta-1, 4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell. J Hepatol. 2008;49(6):1029–37.

    Article  CAS  PubMed  Google Scholar 

  11. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint conrols. Proc Natl Acad SCI U S A. 1995;92(24):11215–9.

    Article  CAS  PubMed  Google Scholar 

  12. DeVincenzo JP. RNA interference strategies as therapy for respiratory viral infections. Pediatr Infect Dis J. 2008;27(10):S118–22.

    PubMed  Google Scholar 

  13. Fire A, et al. Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–11.

    Article  CAS  PubMed  Google Scholar 

  14. Giladi H, et al. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther. 2003;8(5):769–76.

    Article  CAS  PubMed  Google Scholar 

  15. Romano PR, McCallus DE, Pachuk CJ. RNA interference-mediated prevention and therapy for hepatocellular carcinoma. Oncogene. 2006;25(27):3857–65.

    Article  CAS  PubMed  Google Scholar 

  16. Cheng AS, et al. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. Cancer Lett. 2007;253(1):43–52.

    Article  CAS  PubMed  Google Scholar 

  17. Schulze-Bergkamen H, et al. Suppression of mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer. 2006;6:232–40.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xing-e He.

Rights and permissions

Reprints and permissions

About this article

Cite this article

He, Y., Sun, Hq., He, Xe. et al. Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells. Med Oncol 27, 1227–1233 (2010). https://doi.org/10.1007/s12032-009-9363-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-009-9363-0

Keywords

Navigation